tiprankstipranks
Trending News
More News >
Pharming Group (PHAR)
NASDAQ:PHAR
US Market
Advertisement

Pharming Group (PHAR) Technical Analysis

Compare
146 Followers

Technical Sentiment

Overall Consensus
Strong Buy
15Bullish
2Neutral
4Bearish
Technical Analysis Consensus
Sell
3Bullish
2Neutral
4Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Pharming Group’s (PHAR) Moving Averages Convergence Divergence (MACD) indicator is 0.15, suggesting Pharming Group is a Sell.
Pharming Group’s (PHAR) 20-Day exponential moving average is 10.54, while Pharming Group’s (PHAR) share price is $12.25, making it a Buy.
Pharming Group’s (PHAR) 50-Day exponential moving average is 10.37, while Pharming Group’s (PHAR) share price is $12.25, making it a Buy.

Pharming Group (PHAR) Pivot Points

Aug 05, 2025, 03:53 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
9.83
10.19
10.58
10.93
11.32
11.67
12.06
Fibonacci
10.19
10.47
10.65
10.93
11.22
11.39
11.67
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Pharming Group (PHAR) Moving Averages

Aug 05, 2025, 03:53 PM
Period
Simple
Exponential
MA5
10.85Buy
11.14Buy
MA10
10.46Buy
10.74Buy
MA20
10.32Buy
10.54Buy
MA50
10.71Buy
10.37Buy
MA100
9.73Buy
9.96Buy
MA200
9.25Buy
9.38Buy
Pharming Group’s (PHAR) 10-Day exponential moving average is 10.74, while Pharming Group’s (PHAR) share price is $12.25, making it a Buy.
Pharming Group’s (PHAR) 100-Day exponential moving average is 9.96, while Pharming Group’s (PHAR) share price is $12.25, making it a Buy.
Pharming Group’s (PHAR) stock price is $12.25 and Pharming Group’s (PHAR) 50-day simple moving average is 10.71, creating a Buy signal.
Pharming Group’s (PHAR) stock price is $12.25 and Pharming Group’s (PHAR) 100-day simple moving average is 9.73, creating a Buy signal.
Pharming Group’s (PHAR) stock price is $12.25 and Pharming Group’s (PHAR) 200-day simple moving average is 9.25, creating a Buy signal.

Pharming Group (PHAR) Technical Indicators

Aug 05, 2025, 03:53 PM
Name
Value
Implied Action
RSI (14)
68.32
Neutral
STOCH (9,6)
91.01
Sell
STOCHRSI (14)
91.01
Sell
MACD (12,26)
0.15
Sell
ADX (14)
13.37
Buy
Williams %R
0.00
Sell
CCI (14)
325.50
Sell
ATR (14)
0.57
-
Ultimate Oscillator
69.06
Neutral
ROC
21.29
Buy
Pharming Group’s (PHAR) Relative Strength Index (RSI) is 68.32, creating a Neutral signal.
Pharming Group’s (PHAR) Trend Strength Indicator (ADX) is 13.37, creating a Buy signal.
Pharming Group’s (PHAR) Commodity Channel Index (CCI) is 325.50, creating a Sell signal.
Pharming Group’s (PHAR) Price Rate of Change (ROC) is 21.29, creating a Buy signal.

FAQ

Is PHAR a Buy, Hold, or Sell?
Based on PHAR’s technical indicators, PHAR is a Strong Buy.
    What is PHAR’s RSI (14)?
    PHAR’s RSI (14) is 68.32, which suggests PHAR is a Neutral.
      What is PHAR’s MACD?
      PHAR’s MACD is 0.15, which suggests PHAR is a Sell.
        What is PHAR’s 5-day moving average?
        PHAR’s 5-day moving average is 10.85, which suggests PHAR is a Buy.
          What is PHAR’s 20-day moving average?
          PHAR 20-day moving average is 10.32, which suggests PHAR is a Buy.
            What is PHAR’s 50-day moving average?
            PHAR’s 50-day moving average is 10.71, which suggests PHAR is a Buy.
              What is PHAR’s 200-day moving average?
              PHAR’s 200-day moving average is 9.25, which suggests PHAR is a Buy.
                What is PHAR’s Williams % R (14)?
                PHAR’s Williams % R (14) is 0.00, which suggests PHAR is a Sell.
                  What is PHAR’s CCI (14)?
                  PHAR’s CCI (14) is 325.50, which suggests PHAR is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis